Alexander Wilmer
Overview
Explore the profile of Alexander Wilmer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
119
Citations
5818
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanderschueren E, Meersseman P, Wilmer A, Vandecaveye V, Dubois E, Van Eldere A, et al.
Dig Liver Dis
. 2024 Oct;
57(2):549-557.
PMID: 39472174
Background: Sarcopenia is an acknowledged risk factor for individuals with chronic liver disease, however, the influence on outcomes in patients receiving transjugular intrahepatic portosystemic shunt (TIPS) remains underexplored. Aims: This...
2.
Vanderschueren E, Bekhuis Y, Clerick J, Decock J, Meersseman P, Wilmer A, et al.
Ann Hepatol
. 2024 Sep;
30(1):101568.
PMID: 39276990
Introduction And Objectives: TIPS placement is an effective, possibly life-saving, treatment for complications of portal hypertension. The pressure shift induced by the stent can lead to cardiac decompensation (CD). We...
3.
Verhalleman Q, Miserez M, Laenen A, Bonne L, Claus E, Peluso J, et al.
Ann Gastroenterol
. 2024 Sep;
37(5):559-566.
PMID: 39238795
Background: This study evaluated the technical and clinical outcomes of transcatheter arterial embolization (TAE) in patients with acute small-bowel bleeding (SBB) and aimed to identify potential risk factors for early...
4.
Feys S, Cardinali-Benigni M, Lauwers H, Jacobs C, Stevaert A, Goncalves S, et al.
Am J Respir Crit Care Med
. 2024 Jun;
210(10):1230-1242.
PMID: 38865563
The influence of the lung bacterial microbiome, including potential pathogens, in patients with influenza-associated pulmonary aspergillosis (IAPA) or coronavirus disease (COVID-19)-associated pulmonary aspergillosis (CAPA) has yet to be explored. To...
5.
Feio-Azevedo R, Boesch M, Radenkovic S, van Melkebeke L, Smets L, Wallays M, et al.
Hepatology
. 2024 May;
81(2):509-522.
PMID: 38761406
Background And Aims: Acute-on-chronic liver failure (ACLF) is a complication of cirrhosis characterized by multiple organ failure and high short-term mortality. The pathophysiology of ACLF involves elevated systemic inflammation leading...
6.
Frederiks P, Peetermans M, Wilmer A
Eur Heart J Acute Cardiovasc Care
. 2024 Feb;
13(4):373-379.
PMID: 38333990
Optimal care of critically ill patients in the cardiac intensive care unit includes adequate nutritional support. This review highlights the high prevalence of malnutrition in acute heart failure, acute coronary...
7.
Feys S, Vanmassenhove S, Kraisin S, Yu K, Jacobs C, Boeckx B, et al.
Lancet Microbe
. 2024 Jan;
5(3):e247-e260.
PMID: 38280387
Background: COVID-19-associated pulmonary aspergillosis (CAPA) is a severe superinfection with the fungus Aspergillus affecting patients who are critically ill with COVID-19. The pathophysiology and the role of neutrophil extracellular traps...
8.
Gunst J, Debaveye Y, Guiza F, Dubois J, De Bruyn A, Dauwe D, et al.
N Engl J Med
. 2023 Sep;
389(13):1180-1190.
PMID: 37754283
Background: Randomized, controlled trials have shown both benefit and harm from tight blood-glucose control in patients in the intensive care unit (ICU). Variation in the use of early parenteral nutrition...
9.
Vanhoenacker C, Hufkens E, Laenen A, Bonne L, Claus E, Peluso J, et al.
Eur J Radiol
. 2023 Sep;
167:111074.
PMID: 37708676
No abstract available.
10.
Demuynck T, Wilmer A, Meijers B
Clin J Am Soc Nephrol
. 2023 Sep;
18(11):1507-1509.
PMID: 37699660
No abstract available.